Silvant Capital Management’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-17,231
Closed -$416K 320
2025
Q1
$416K Hold
17,231
0.02% 162
2024
Q4
$693K Hold
17,231
0.03% 153
2024
Q3
$1.09M Hold
17,231
0.05% 141
2024
Q2
$913K Hold
17,231
0.04% 146
2024
Q1
$1.41M Buy
+17,231
New +$1.41M 0.07% 137